BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 02/11/2018

FDA Announces Draft Guidance for Chronic Hepatitis B Virus Infection Treatment

The FDA is releasing a draft guidance to help pharmaceutical companies develop effective treatments for chronic hepatitis B virus infection, covering the entire drug development process from initial testing to post-marketing phases.

Source: Federal Register — Food and Drug AdministrationOpen original release →